Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00393380 · OUTCOME

100-day Transplant-related Mortality

Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated Donor · Source last updated 2013-04-29

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
participants
Interval / dispersion
Not reported
Time frame
Measured at Day 100

What was measured

100-day transplant-related mortality

Analysis population: 13 patients were transplanted

Groups in this outcome

Parathyroid Hormone (Teriparatide)

Parathyroid hormone after double umbilical cord blood transplant.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Parathyroid Hormone (Teriparatide)13

Reported measurements

Source class 1
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Parathyroid Hormone (Teriparatide)4Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        4
denoms
  1. counts
    1. group Id
      OG000
      value
      13
    units
    Participants
description
100-day transplant-related mortality
groups
  1. description
    Parathyroid hormone after double umbilical cord blood transplant.
    id
    OG000
    title
    Parathyroid Hormone (Teriparatide)
param Type
NUMBER
population Description
13 patients were transplanted
reporting Status
POSTED
time Frame
Measured at Day 100
title
100-day Transplant-related Mortality
type
SECONDARY
unit Of Measure
participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice